These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21507259)

  • 1. Indian vaccine innovation: the case of Shantha Biotechnics.
    Chakma J; Masum H; Perampaladas K; Heys J; Singer PA
    Global Health; 2011 Apr; 7():9. PubMed ID: 21507259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Children's Vaccine Initiative and vaccine supply: the role of the public sector.
    van Noort RB
    Vaccine; 1992; 10(13):909-10. PubMed ID: 1471410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector.
    Martinez-Grau MA; Alvim-Gaston M
    Pharmaceut Med; 2019 Jun; 33(3):193-198. PubMed ID: 31933287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer.
    Anyakora C; Ekwunife O; Alozie F; Esuga M; Ukwuru J; Onya S; Nwokike J
    BMC Health Serv Res; 2017 Sep; 17(1):665. PubMed ID: 28923044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complexity and cost of vaccine manufacturing - An overview.
    Plotkin S; Robinson JM; Cunningham G; Iqbal R; Larsen S
    Vaccine; 2017 Jul; 35(33):4064-4071. PubMed ID: 28647170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen.
    Adis International Ltd
    Drugs R D; 2003; 4(4):249-53. PubMed ID: 12848591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges constraining access to insulin in the private-sector market of Delhi, India.
    Sharma A; Kaplan WA
    BMJ Glob Health; 2016; 1(3):e000112. PubMed ID: 28588966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia.
    Coghlan R; Stephens P; Mwale B; Siyanga M
    Malar J; 2018 Nov; 17(1):444. PubMed ID: 30497504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The art of partnerships for vaccines.
    Pagliusi S; Che Y; Dong S
    Vaccine; 2019 Sep; 37(40):5909-5919. PubMed ID: 31447125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing R&D models in research-based pharmaceutical companies.
    Schuhmacher A; Gassmann O; Hinder M
    J Transl Med; 2016 Apr; 14(1):105. PubMed ID: 27118048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geneva-Seattle collaboration in support of developing country vaccine manufacturing.
    Stevenson MA
    Glob Public Health; 2018 Apr; 13(4):426-441. PubMed ID: 27760489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study.
    Jung YL; Hwang J; Yoo HS
    Global Health; 2020 Sep; 16(1):80. PubMed ID: 32912258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affordably priced new drugs for poor populations: Approaches for a global solution.
    Mossialos E; Dukes G
    Int J Risk Saf Med; 2001; 14(1):1-29. PubMed ID: 22388482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Big-pharmaceuticalisation: clinical trials and Contract Research Organisations in India.
    Sariola S; Ravindran D; Kumar A; Jeffery R
    Soc Sci Med; 2015 Apr; 131():239-46. PubMed ID: 25476783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shaping markets to benefit global health - A 15-year history and lessons learned from the pentavalent vaccine market.
    Malhame M; Baker E; Gandhi G; Jones A; Kalpaxis P; Iqbal R; Momeni Y; Nguyen A
    Vaccine X; 2019 Aug; 2():100033. PubMed ID: 31384748
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.